Instil Bio, Inc.

NASDAQ:TIL

19.06 (USD) • At close March 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -74.135-156.087-223.177-156.794-37.738-6.522
Depreciation & Amortization 3.614.7565.9872.7520.2560.02
Deferred Income Tax 0000.71-0.6430
Stock Based Compensation 17.25718.16630.44126.1971.7060.293
Change In Working Capital -12.605-9.016-9.5664.3611.4750.366
Accounts Receivables 000000
Inventory 000000
Accounts Payables -0.556-1.129-1.8063.862-1.0540.309
Other Working Capital -12.049-7.887-7.760.4992.5290.057
Other Non Cash Items 10.17760.15216.1510.6365.3280.55
Operating Cash Flow -55.696-82.029-180.164-122.138-29.616-5.293
Investing Activities:
Investments In Property Plant And Equipment 0-20.663-84.589-57.831-50.816-0.76
Acquisitions Net 001.1740-0.3060
Purchases Of Investments -134.009-301.466-666.22-1,107.56500
Sales Maturities Of Investments 198.1361.7865.3569100
Other Investing Activites -10.1171.557-1.17400-0.55
Investing Cash Flow 53.97441.128114.541-474.396-51.122-0.76
Financing Activities:
Debt Repayment 2.7628.08270.338000
Common Stock Issued 001.548339.016312.98314.948
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities -1.00701.54854.148313.04814.948
Financing Cash Flow 1.7558.08271.886393.164313.04814.948
Other Information:
Effect Of Forex Changes On Cash -0.094-0.201-0.637-0.3040.5590
Net Change In Cash -0.061-33.025.626-203.674232.8698.895
Cash At End Of Period 10.63510.69643.71638.09241.7648.895